![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 27, 2019 1:52:23 PM
Mr. Kim K. Thompson is the Founder of Kraig Biocraft Laboratories, Inc. and has been its Chief Executive Officer and President since April 2006. Mr. Thompson serves as Chief Financial Officer at Kraig Biocraft Laboratories, Inc. He founded California Law Firm of Ching & Thompson in 1997. He has been Partner of Illinois Law Firm of McJessy, Ching & Thompson since 2004. Mr. Thompson founded Kraig Biocraft Laboratories , Inc. in his pursuit of the development of new biotechnologies with industrial applications. Mr. Thompson brings a wealth of experience in business management and consultation to Kraig. Mr. Thompson was the director of business development at Franchise Venture Partners, LLC. He subsequently joined the firm of Shearson, Lehman, Hutton where he specialized in equity trading and research of small-cap companies. Mr. Thompson received the highest series seven score for all Shearson brokers in his class nationwide. His experience in those small-cap equity markets has proven to be invaluable both in his legal and business successes. He serves as the Chairman at Kraig Biocraft Laboratories, Inc. and has been its Director since April 25, 2006. He specialized in Commercial Litigation from California law firm of Ching & Thompson and Illinois law firm of McJessy, Ching & Thompson. Mr. Thompson studied Bachelor's degree in Applied Economics from James Madison College, Michigan State University and his Juris Doctorate from the University of Michigan Law School in 1994.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM